ArticleMolecular medicine reports2026

Glucose‑driven TRIB3 enhances the tumorigenic potential of colon cancer via the PI3K/AKT pathway.

Yunting Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.